Application of prothrombin complex concentrates for perioperative bleeding therapy in cardiac-surgical patients

References

1. Grottke O., Levy J.H. Prothrombin complex concentrates in trauma and perioperative bleeding. Anesthesiology. 2015; 122: 923–31.
2. Bruning P.F. Purification and clinical application of the four factors of the prothrombin complex. In: Hemker H.C., Loeliger E.A., Veltkamp J.J. (Eds) Human blood coagulation. Boerhaave series for postgraduate medical education (proceedings of the Boerhaave Courses Organized by the Faculty of Medicine, University of Leiden, The Netherlands). Dordrecht: Springer; 1969; 1: 251. DOI: 10.1007/978-94-010-3423-4_29
3. Tullis J.L., Melin M., Jurigian P. Clinical use of human prothrombin complexes. N. Engl. J. Med. 1965; 273 (13): 667–74. DOI: 10.1056/NEJM196509232731301
4. Haanen C., McShine R.L., Kunst A. Preparation and clinical use of Factor IX concentrate PPSB according to soulier. Vox. Sang. 1969; 16 (Is. 5): 398–411.
5. Key N.S., Negrier C. Coagulation factor concentrates: past, present, and future. Lancet. 2007; 370: 439–48. DOI: 10.1016/S0140-6736(07)61199-4
6. Sоrensen B., Spahn D.R., Innerhofer P., Spannagl M., Rossaint R. Clinical review: prothrombin complex concentrates – evaluation of safety and thrombogenicity. Crit. Care. 2011; 15: 201.
7. Baglin T.P., Keeling D.M., Watson H.G. Guidelines on oral anticoagulation (warfarin): third edition – 2005 update. Br. J. Haematol. 2006; 132: 277–85.
8. Ghadimi K., Levy J.H., Welsby I.J. Prothrombin complex concentrates for bleeding in the perioperative setting. Anesth. Analg. 2016; 122: 1287–300.
9. Chai-Adisaksopha C., Hillis C., Siegal D.M., Movilla R., Heddle N., Iorio A. et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb. Haemost. 2016; 116: 879–90.
10. Fries D., Haas T., Klingler A., Steif W., Klima G., Martini J. et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy – a porcine model. Br. J. Anaesth. 2006; 97: 460–7.
11. Dickneite G., Doerr B., Kaspereit F. Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate. Anesth. Analg. 2008; 106: 1070–7.
12. Dickneite G., Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br. J. Anaesth. 2009; 102 (3): 345–54. DOI: 10.1093/bja/aen391
13. Schochl H., Voelckel W., Maegele M., Kirchmair L., Schlimp C.J. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit. Care. 2014; 18: R147.
14. Lusher J. Thrombogenicity associated with factor IX complex concentrates. Semin. Hematol. 1991; 28: 3–5.
15. Галстян Г.М. Нарушения гемостаза, обусловленные дефицитом витамин К-зависимых факторов свертывания крови – патогенез, способы коррекции и рекомендации по лечению. Гематология и трансфузиология. 2012; 57 (2): 7–21. [Galstyan G.M. Hemostasis disorders caused by deficiency of vitamin k-dependent coagulation factors: pathogenesis, correction methods and recommendations for treatment. Gematologiya i Transfuziologiya (Hematology and Transfusiology, Russian journal). 2012; 57 (2): 7–21(in Russ.).]
16. Giles A.R., Nesheim M.E., Hoogendorn H., Tracy P.B., Mann K.G. The coagulant active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (factor IX) concentrates in rabbits. Blood. 1982; 59: 401–7.
17. Köhler M. Thrombogenicity of prothrombin complex concentrates. Thromb. Res. 1999; 95 (4, Suppl. 1): S13–7.
18. Bui J.D., Despotis G.D., Trulock E.P., Patterson G.A., Goodnough L.T. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J. Thorac. Cardiovasc. Surg. 2002; 124: 852–4.
19. Rao V.K., Lobato R.L., Bartlett B., Klanjac M., MoraMangano C.T., Soran P.D. et al. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2014; 28 (5): 1221–6. DOI: 10.1053/j.jvca.2014.04.015
20. Avidan M., Levy J., Scholz J., Delphin E., Rosseel P.M., Howie M.B. et al. A phase III, double-blind, placebocontrolled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass. Anesthesiology. 2005; 102: 276–84.
21. Grottke O., Rossaint R., Henskens Y. Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model. PLoS ONE. 2013; 8: e64100.
22. Leissinger C.A., Blatt P.M., Hoots W.K., Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am. J. Hematol. 2008; 83: 137–43.
23. Hanke A.A., Joch C., Gorlinger K. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br. J. Anesth. 2013; 110: 764–72.
24. Guzzetta N.A., Williams G.D. Current use of factor concentrates in pediatric cardiac anesthesia. Paediatr. Anaesth. 2017; 27 (7): 678–87. DOI: 10.1111/pan.13158
25. Leggett P.L., Doyle D., Smith W.B., Culpepper W. 3rd, Cooper S., Ochsner J.L. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies. J. Thorac. Cardiovasc. Surg. 1984; 87 (4): 556–60.
26. Rauch R., Hofbeck M., Ries M., Singer H., Klinge J. Emergency correction of coagulation for mitral valve replacement in an orally anticoagulated 17-year-old patient with pronounced hepatic dysfunction. Intensive Care Med. 1999; 25 (10): 1131–3.
27. Stuklis R.G., O'Shaughnessy D.F., Ohri S.K. Novel approach to bleeding in patients undergoing cardiac surgery with liver dysfunction. Eur. J. Cardiothorac. Surg. 2001; 19 (2): 219–20.
28. Fraser T.A., Corke C.F., Mohajeri M., Stevenson L., Campbell P.J. A retrospective audit of the use of Prothrombinex-HT for refractory bleeding following adult cardiac surgery. Crit. Care Resusc. 2006; 8: 141–5.
29. Bruce D., Nokes T.J. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit. Care. 2008; 12: R105.
30. Demeyere R., Gillardin S., Arnout J., Strengers P.F. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox. Sang. 2010; 99: 251–60.
31. Arnekian V., Camous J., Fattal S., Rézaiguia-Delclaux S., Nottin R., Stéphan F. Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact. Cardiovasc. Thorac. Surg. 2012; 15: 382–9.
32. Мамаева С.А., Пичугин В.В., Богуш А.В., Пичугина М.В., Волкова Н.А. Применение препарата Протромплекс 600 для лечения кровотечения во время и после реконструктивных операций на сердце и сосудах в условиях искусственного кровообращения. Тромбоз, гемостаз и реология. 2012; 1 (49): 1–7. [Mamaeva S.A., Pichugin V.V., Bogush A.V., Pichugina M.V., Volkova N.A. Application of prothromplex 600 for treatment of bleedings during and after reconstructive operations on heart and vessels in conditions of cardiopulmonary bypass. Tromboz, Gemostaz i Reologiya (Thrombosis, Hemostasis and Rheology, Russian journal). 2012; 1 (49): 1–7 (in Russ.).]
33. Григорьев Е.В., Плотников Г.П., Шукевич Д.Л., Груздева О.В., Пенская Т.Ю., Хаес Б.Л. Концентрат протромбинового комплекса при кардиохирургических операциях: анализ эффективности и безопасности. Вестник анестезиологии и реаниматологии. 2014; 11 (3): 17–23. [Grigor'ev E.V., Plotnikov G.P., Shukevich D.L., Gruzdeva O.V., Penskaya T.Yu., Khaes B.L. Concentrate prothrombin complex in cardiac surgery: analysis of efficacy and safety. Vestnik Anesteziologii i Reanimatologii (Bulletin of Anesthesiology and Intensive Care). 2014; 11 (3): 17–23 (in Russ.).]
34. Селюн Ю.А., Валентюкевич А.В., Островский Ю.П. Коррекция гипокоагуляционного кровотечения при кардиохирургических вмешательствах. Тезисы IV Евразийского конгресса кардиологов. Евразийский кардиологический журнал. 2016; 3: 99. [Selyun Yu.A., Valentyukevich A.V., Ostrovskiy Yu.P. Correction of hypocoagulation bleeding in cardiosurgical interventions. Abstracts of the IV Eurasian Congress of Cardiologists. Evraziyskiy Kardiologicheskiy Zhurnal (Eurasian Heart Journal, Russian journal). 2016; 3: 99 (in Russ.).]
35. Селюн Ю.А., Валентюкевич А.В., Колядко М.Г., Островский Ю.П. Использование концентрата протромбинового комплекса в дифференцированной терапии нарушений системы гемостаза при трансплантации сердца. Медицинские новости. 2013; 10: 49–52. [Seliun Yu.A., Valentsiukevich A.V., Kaliadka M.G., Ostrovsky Yu.P. Usage of prothrombin complex concentrate in differentiated therapy of hemostatic system disorders in heart transplantation. Meditsinskie Novosti (Medical News, Belarussian journal). 2013; 10: 49–52 (in Russ.).]
36. Ortmann E., Besser M.W., Sharples L.D., Gerrard C., Berman M., Jenkins D.P. et al. An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth. Analg. 2015; 121: 26–33.
37. Cappabianca G., Mariscalco G., Biancari F., Maselli D., Papesso F., Cottini M. et al. Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. Crit. Care. 2016; 20: 5.
38. Gorlinger K., Dirkmann D., Hanke A.A., Kamler M., Kottenberg E., Thielmann M. et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology. 2011; 115: 1179–91.
39. Ranucci M., Baryshnikova E., Crapelli G.B., RaheMeyer N., Menicanti L., Frigiola A. Surgical Clinical Outcome REsearch (SCORE) Group. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J. Am. Heart Assoc. 2015; 4 (6): e002066.
40. Kremers R.M., Bosch Y.P., Bloemen S., de Laat B., Weerwind P.W., Mochtar B. et al. A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding. Thromb. Haemost. 2016; 116 (3): 442–51. DOI: 10.1160/TH16-02-0094
41. Percy C.L., Hartmann R., Jones R.M., Balachandran S., Mehta D., Dockal M. et al. Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass. Blood Coagul. Fibrinol. 2015; 26: 357–67.
42. Franklin S., Szlam F., Fernandez J., Leong T., Tanaka K., Guzzetta N. Optimizing thrombin generation with 4-factor prothrombin complex concentrates in neonatal plasma after cardiopulmonary bypass. Anesth. Analg. 2016; 122: 935–42.
43. Smith M.M., Ashikhmina E., Brinkman N.J., Barbara D.W. Perioperative use of coagulation factor concentrates in patients undergoing cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2017; 31 (5): 1810–9. DOI: 10.1053/j.jvca.2017.05.017
44. Kuhle S., Male C., Mitchell L. Developmental hemostasis: proand anticoagulant systems during childhood. Semin. Thromb. Hemost. 2003; 29: 329–37.
45. Cvirn G., Gallistl S., Muntean W. Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb. Res. 1999; 93: 183–90.
46. Andrew M., Paes B., Johnston M. Development of the hemostatic system in the neonate and young infant. Am. J. Pediatr. Hematol. Oncol. 1990; 12: 95–104.
47. Miller B.E., Tosone S.R., Guzzetta N.A., Miller J.L., Brosius K.K. Fibrinogen in children undergoing cardiac surgery: is it effective? Anesth. Analg. 2004; 99: 1341–6.
48. Brown A.C., Hannan R., Timmins L.H., Fernandez J.D., Barker T.H., Guzzetta N.A. Fibrin network changes in neonates after cardiopulmonary bypass. Anesthesiology. 2016; 124: 1021–31.
49. Wolberg A. Thrombin generation and fibrin clot structure. Blood Rev. 2007; 21: 131–42.
50. Wolberg A.S., Monroe D.M., Roberts H.R., Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood. 2003; 101: 3008–13.
51. Ashikhmina E., Said S., Smith M.M., Rodriguez V., Oliver W.C. Jr., Nuttall G.A. et al. Prothrombin complex concentrates in pediatric cardiac surgery: the current state and the future. Ann. Thorac. Surg. 2017; 104 (4): 1423–31.
52. Giorni C., Ricci Z., Iodice F., Garisto C., Favia I., Polito A. et al. Use of confidex to control perioperative bleeding in pediatric heart surgery: prospective cohort study. Pediatr. Cardiol. 2014; 35: 208–14.
53. Самсонова Н.Н., Рыбка М.М., Климович Л.Г., Рогальская Е.А., Хинчагов Д.Я., Татарян Ф.Э. и др. Применение концентрата протромбинового комплекса у детей раннего возраста, оперированных на сердце в условиях искусственного кровообращения. Тромбоз, гемостаз и реология. 2015; 1 (61): 22–7. [Samsonova N.N., Rybka M.M., Klimovich L.G., Rogal’skaya E.A., Khinchagov D.Ya., Tataryan F.E. et al. Use of prothrombin complex concentrate in early infants undergoing cardiac surgery with cardiopulmonary bypass. Tromboz, Gemostaz i Reologiya (Thrombosis, Hemostasis and Rheology, Russian journal). 2015; 1 (61): 22–7 (in Russ.).]
54. Рыбка М.М., Рогальская Е.А., Самсонова Н.Н., Климович Л.Г., Мумладзе К.В., Хинчагов Д.Е. и др. Коррекция нарушений гемостаза концентратом протромбинового комплекса после операций на открытом сердце у новорожденных и детей первого года жизни. Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2017; 18 (Прил. 3): 102. [Rybka M.M., Rogal’skaya E.A., Samsonova N.N., Klimovich L.G., Mumladze K.V., Khinchagov D.E. et al. Correction of hemostasis disturbances by the concentrate of the protombin complex after open operations in the newborn children of the first year of life. Serdechno-Sosudistye Zabolevaniya. Byulleten' Nauchnogo Tsentra Serdechno-Sosudistoy Khirurgii imeni A.N. Bakuleva Rossiyskoy Akademii Meditsinskikh Nauk (Bulletin of Bakoulev Center for Cardiovascular Disease, Russian journal). 2017; 18 (Suppl. 3): 102 (in Russ.).]
55. Ермолович Ю.В., Ящук Н.С., Бойко С.М., Лазоришинець В.В. Опыт применения концентрата протромбинового комплекса (КПК) в лечении периоперационного кровотечения при хирургической коррекции сложных врожденных пороков сердца у новорожденных и детей первого года жизни. http://lib.inmeds.com.ua:8080/jspui/handle/ lib/2976 (дата обращения 20.03.2018). [Ermolovich Yu.V., Yashchuk N.S. , Boyko S.N., Lazorishinets V.V. Experience of prothrombin concentrates complex (PCC) usage for perioperative bleeding treatment in newborns and infants following complex cardiac surgery (in Russ.). Available at: http://lib. inmeds.com.ua:8080/jspui/handle/lib/2976 (accessed 20 March 2018).]
56. 5Noga T., Bruce A., Blian H., Nahirniak S. Four-factor prothrombin complex concentrates in paediatric patients – a retrospective case series. Vox. Sang. 2016; 110: 253–7.
57. 5Jooste M., Machovec K., Einhorn L., Ames W.A., Homi H.M., Jaquiss R.D. et al. 3-Factor prothrombin complex сoncentrates in infants with refractory bleeding after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2016; 30: 1627–31.
58. Navaratnam M., Ng A., Williams G., Maeda K., Mendoza J.M., Concepcion W. et al. Perioperative management of pediatric en-bloc combined heart-liver transplants: a case series review. Paediatr. Anaesth. 2016; 26: 976–86.
59. Lee J., Ing C. Prothrombin complex concentrate and methylene blue for treatment of coagulopathy and vasoplegia in a pediatric heart transplant patient. A&A Case Rep. 2016; 6: 127–9.
60. Ломиворотов В.В., Шмырев В.А., Дерягин М.Н., Ефремов С.М., Корнилов И.А., Чернявский А.М. Применение концентрата протромбинового комплекса при трансплантации сердца после имплантации системы механической поддержки левого желудочка. Общая реаниматология. 2012; 6 (8): 44–7. [Lomivorotov V.V., Shmyrev V.A., Deryagin M.N., Efremov S.M., Kornilov I.A., Chernyavskiy A.M. Use of prothrombin complex concentrate in patients during heart transplantation after implantation of a left ventricular mechanical support system. Obshchaya Reanimatologiya (General Reanimatology, Russian journal). 2012; 6 (8): 44–7 (in Russ.).]

About Authors